CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $152,000 | +47.6% | 38,010 | 0.0% | 0.88% | +99.3% |
| Q2 2020 | $103,000 | +28.8% | 38,010 | 0.0% | 0.44% | -52.9% |
| Q1 2020 | $80,000 | -61.4% | 38,010 | 0.0% | 0.94% | +81.9% |
| Q4 2019 | $207,000 | +81.6% | 38,010 | 0.0% | 0.51% | +102.4% |
| Q3 2019 | $114,000 | -89.3% | 38,010 | -86.7% | 0.25% | -75.6% |
| Q2 2019 | $1,065,000 | -7.0% | 284,869 | 0.0% | 1.04% | +11.9% |
| Q1 2019 | $1,145,000 | +9.6% | 284,869 | 0.0% | 0.93% | -21.9% |
| Q4 2018 | $1,045,000 | – | 284,869 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
| TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
| Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
| CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
| BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
| SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
| MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |